Therapy by Drugs Affecting Gastrointestinal Motility in Patients with Dyspepsia

Abstract

Drugs acting on gastrointestinal motility have been tried in patients with so called functional dyspepsia. Some aspects of these trials will be discussed here. The therapeutic effects are difficult to summarize for several reasons. One problem is that there is no universally accepted definition of dyspepsia (1). In most studies functional dyspepsia refers to a constellation of symptoms from the upper abdomen, and thought to emanate from proximal parts of the gastrointestinal tract, particularly the stomach. The symptoms should not be associated with morphological or chemical abnormalities which can explain the complaints of the patients.